Literature DB >> 33607952

Coronavirus disease 2019 (COVID-19) can predispose young to Intracerebral hemorrhage: a retrospective observational study.

Michael T Lawton1, Ehsan Alimohammadi2, Seyed Reza Bagheri3, Arash Bostani4, Siavash Vaziri5, Ali Karbasforoushan6, Kossar Mozaffari7, Mehran Bahrami Bukani3, Alireza Abdi8.   

Abstract

BACKGROUND: The respiratory system involvement is the most common presentation of Coronavirus disease 2019 (COVID-19). However, other organs including the central nervous system (CNS) could be affected by the virus. Strokes, seizures, change in mental status, and encephalitis have been reported as the neurological manifestation of the disease. We hypothesized that COVID-19 could predispose younger patients to spontaneous intracerebral hemorrhage (ICH). The present study aimed to investigate whether COVID-19 has any relationship with the occurrence of spontaneous ICH in young or not.
METHODS: We retrospectively evaluated all the patients with spontaneous ICH who were referred to our center between 20 Feb and 1 Sep 2020. The demographic, clinical, radiological, and laboratory test data were evaluated. Patients were divided into two groups. The COVID-19 positive patients and COVID-19 negative ones. All the variables including age, sex, history of hypertension, diabetes mellitus, smoking, Glasgow Coma Scale (GCS), hematoma volume and location, the presence of intraventricular hemorrhage and hydrocephalus on admission, the length of hospital stay, the lab test results and the clinical outcome at last visit or discharge as Glasgow Outcome Scale (GOS) were compared between the two groups.
RESULTS: There were 22 COVID-19 positive patients (20.8%) and 84 COVID-19 negative ones (79.2%). The mean age of the patients in the case group (54.27 ± 4.67) was significantly lower than that in the control group (69.88 ± 4.47) (p < 0.05). Meanwhile, our results showed a significant difference between the two groups based on the presence of chronic arterial hypertension (p < 0.05). There were no significant differences between the two groups based on gender, diabetes mellitus, smoking, Glasgow Coma Scale (GCS), hematoma volume, need for surgery, the presence of intraventricular hemorrhage and hydrocephalus on admission, White Blood Cell (WBC) count, platelet count, Prothrombin Time (PT), and Partial Thromboplastin Time (PTT) (p > 0.05).
CONCLUSIONS: Our results show that COVID positive patients with ICH are younger and with less predisposing factors than COVID negative subjects with ICH.

Entities:  

Keywords:  Central nervous system; Coronavirus disease 2019; Intracerebral hemorrhage; chronic arterial hypertension, hematoma.

Mesh:

Year:  2021        PMID: 33607952      PMCID: PMC7892324          DOI: 10.1186/s12883-021-02109-8

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  23 in total

Review 1.  Spontaneous intracerebral hemorrhage.

Authors:  A I Qureshi; S Tuhrim; J P Broderick; H H Batjer; H Hondo; D F Hanley
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

2.  Impact of influenza vaccination on major cause-specific mortality.

Authors:  Chong-Shan Wang; Shan-Tair Wang; Ching-Te Lai; Li-Jen Lin; Pesus Chou
Journal:  Vaccine       Date:  2006-10-25       Impact factor: 3.641

3.  The Charcot-Bouchard controversy.

Authors:  V J Iragui
Journal:  Arch Neurol       Date:  1986-03

4.  Influenza virus infection aggravates stroke outcome.

Authors:  Sajjad Muhammad; Emanuel Haasbach; Maria Kotchourko; Anne Strigli; Antje Krenz; Dirk A Ridder; Annette B Vogel; Hugo H Marti; Yousef Al-Abed; Oliver Planz; Markus Schwaninger
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

5.  The Charcôt-Bouchard aneurysm controversy: impact of a new histologic technique.

Authors:  V R Challa; D M Moody; M A Bell
Journal:  J Neuropathol Exp Neurol       Date:  1992-05       Impact factor: 3.685

6.  Middle East Respiratory Syndrome.

Authors:  Yaseen M Arabi; Hanan H Balkhy; Frederick G Hayden; Abderrezak Bouchama; Thomas Luke; J Kenneth Baillie; Awad Al-Omari; Ali H Hajeer; Mikiko Senga; Mark R Denison; Jonathan S Nguyen-Van-Tam; Nahoko Shindo; Alison Bermingham; James D Chappell; Maria D Van Kerkhove; Robert A Fowler
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

7.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.

Authors:  Yanan Li; Man Li; Mengdie Wang; Yifan Zhou; Jiang Chang; Ying Xian; David Wang; Ling Mao; Huijuan Jin; Bo Hu
Journal:  Stroke Vasc Neurol       Date:  2020-07-02

8.  Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description.

Authors:  Francisco Hernández-Fernández; Hernán Sandoval Valencia; Rosa Angélica Barbella-Aponte; Rosa Collado-Jiménez; Óscar Ayo-Martín; Cristina Barrena; Juan David Molina-Nuevo; Jorge García-García; Elena Lozano-Setién; Cristian Alcahut-Rodriguez; Álvaro Martínez-Martín; Antonio Sánchez-López; Tomás Segura
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

Review 9.  COVID-19 and cerebrovascular diseases: a comprehensive overview.

Authors:  Georgios Tsivgoulis; Lina Palaiodimou; Ramin Zand; Vasileios Arsenios Lioutas; Christos Krogias; Aristeidis H Katsanos; Ashkan Shoamanesh; Vijay K Sharma; Shima Shahjouei; Claudio Baracchini; Charalambos Vlachopoulos; Rossetos Gournellis; Petros P Sfikakis; Else Charlotte Sandset; Andrei V Alexandrov; Sotirios Tsiodras
Journal:  Ther Adv Neurol Disord       Date:  2020-12-08       Impact factor: 6.570

View more
  3 in total

Review 1.  Treating the body to prevent brain injury: lessons learned from the coronavirus disease 2019 pandemic.

Authors:  Tracey H Fan; Veronika Solnicky; Sung-Min Cho
Journal:  Curr Opin Crit Care       Date:  2022-04-01       Impact factor: 3.687

2.  Intracerebral Hemorrhage in COVID-19 Infection.

Authors:  Jem Atillasoy; Audrey C Leasure; Kevin N Sheth
Journal:  World Neurosurg       Date:  2021-09       Impact factor: 2.104

3.  Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study.

Authors:  Junichi Nakamura; Ichizo Tsujino; Sen Yachi; Makoto Takeyama; Yuji Nishimoto; Satoshi Konno; Naoto Yamamoto; Hiroko Nakata; Satoshi Ikeda; Michihisa Umetsu; Shizu Aikawa; Hiroya Hayashi; Hirono Satokawa; Yoshinori Okuno; Eriko Iwata; Yoshito Ogihara; Nobutaka Ikeda; Akane Kondo; Takehisa Iwai; Norikazu Yamada; Tomohiro Ogawa; Takao Kobayashi; Makoto Mo; Yugo Yamashita
Journal:  Thromb J       Date:  2022-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.